Emerson’s fourth quarter results received a positive market response, as the company met Wall Street’s revenue expectations ...

Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026 Adaptive Biotechnologies ...

Good afternoon, and thank you for joining us on our fourth quarter and full year earnings call. As shown on Slide 3, in the MRD business, full year revenue grew 46% year-over-year, and we achieved ...

Overview Serverless analytics removes the complexity of infrastructure in big data workloads.Scalable Spark and Hive jobs ...

Understand the advantages of PC-driven hearing tests over legacy equipment in terms of cost, scalability, and usability.

Engineering and automation solutions company Emerson (NYSE:EMR) met Wall Streets revenue expectations in Q4 CY2025, with ...

Emerson Electric Co (EMR) reports robust order growth and increased earnings, despite facing headwinds in Europe and China.

Emerson Electric (NYSE:EMR) reported first-quarter fiscal 2026 results that management said reflected “disciplined execution” ...

Impenetrable portals and long logins are causing patients to think of technology as a hindrance to healthcare access.

Most readers would already be aware that Emerson Electric's (NYSE:EMR) stock increased significantly by 8.8% over ...

Will it be cheaper? Can you use railcards with the app? Will I be forced to use it? These are just some of the questions you asked after it was announced that East Midlands Railway (EMR) would be ...